Hyperuricaemia and accelerated reduction in renal function. (Q51152490)

31 March 2018

title

Hyperuricaemia and accelerated reduction in renal function. (English)

1 reference

31 March 2018

author

Lai-Chu See

3

1 reference

31 March 2018

author name string

C-F Kuo

1

1 reference

31 March 2018

S-F Luo

2

1 reference

31 March 2018

Y-S Ko

4

1 reference

31 March 2018

Y-M Chen

5

1 reference

31 March 2018

J-S Hwang

6

1 reference

31 March 2018

I-J Chou

7

1 reference

31 March 2018

H-C Chang

8

1 reference

31 March 2018

H-W Chen

9

1 reference

31 March 2018

K-H Yu

10

1 reference

31 March 2018

publication date

26 September 2010

1 reference

31 March 2018

Scandinavian Journal of Rheumatology

published in

1 reference

31 March 2018

volume

40

1 reference

31 March 2018

page(s)

116-121

1 reference

31 March 2018

issue

2

1 reference

31 March 2018

Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Relationship of uric acid with progression of kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Predictors of new-onset decline in kidney function in a general middle-european population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

The 10-year incidence of renal insufficiency in people with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Hyperuricemia and incidence of hypertension among men without metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

A role for uric acid in the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Renal outcomes of gout and hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Mild hyperuricemia and subclinical renal damage in untreated primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Uric acid and incident kidney disease in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Elevated uric acid increases the risk for kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Hyperuricemia induces endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Hyperuricemia in coronary, cerebral and peripheral arterial disease: An explanation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009742.2010.507218

10.3109/03009742.2010.507218

21 January 2018

Identifiers

DOI

1 reference

31 March 2018

PubMed ID

20868309

1 reference

31 March 2018